Cargando…
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
Autores principales: | Ghione, Paola, Gu, Juan J., Attwood, Kristopher, Torka, Pallawi, Goel, Shipra, Sundaram, Suchitra, Mavis, Cory, Johnson, Michael, Thomas, Roshneke, McWhite, Kenneth, Darrall, Andrea, DeMarco, Joseph, Kostrewa, Jessica, Mohr, Alice, Rivas, Leah, Neiders, Mirdza, Suresh, Lakshmanan, Segal, Brahm H., Griffiths, Elizabeth A., Ramsperger, Vince, Shen, Long, Hernandez-Ilizaliturri, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245303/ https://www.ncbi.nlm.nih.gov/pubmed/34189565 http://dx.doi.org/10.1182/blood.2021012443 |
Ejemplares similares
-
Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy
por: Goel, Shipra, et al.
Publicado: (2021) -
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
por: Torka, Pallawi, et al.
Publicado: (2022) -
Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
por: Goel, Shipra, et al.
Publicado: (2022) -
Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma
por: Torka, Pallawi, et al.
Publicado: (2020) -
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma
por: Singh, Anil R., et al.
Publicado: (2020)